Align Technology, Inc (ALGN) is a leading medical devices business based in the US. It opened the day at $507 after a previous close of $508.39. During the day the price has varied from a low of $498.255 to a high of $509.5. The latest price was $507.08 (25 minute delay). Align Technology is listed on the NASDAQ and employs 14,530 staff. All prices are listed in US Dollars.
Since the stock market crash in March caused by coronavirus, Align Technology's share price has had significant positive movement.
Its last market close was $326.84, which is 20.37% up on its pre-crash value of $260.26 and 155.58% up on the lowest point reached during the March crash when the shares fell as low as $127.88.
If you had bought $1,000 worth of Align Technology shares at the start of February 2020, those shares would have been worth $543.99 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,291.02.
|52-week range||$127.88 - $543.654|
|50-day moving average||$491.8897|
|200-day moving average||$360.0567|
|Wall St. target price||$472.21|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$21.976|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2021-01-08)||-11.12%|
|1 month (2020-12-18)||-4.31%|
|3 months (2020-10-16)||50.68%|
|6 months (2020-07-17)||57.33%|
|1 year (2020-01-17)||80.65%|
|2 years (2019-01-17)||138.44%|
|3 years (2018-01-17)||86.26%|
|5 years (2016-01-15)||747.11%|
Valuing Align Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Align Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Align Technology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Align Technology shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Align Technology's P/E ratio is best considered in relation to those of others within the medical devices industry or those of similar companies.
Align Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.9394. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Align Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Align Technology's PEG ratio in relation to those of similar companies.
Align Technology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $421.6 million (£0.0 million).
The EBITDA is a measure of a Align Technology's overall financial performance and is widely used to measure a its profitability.
To put Align Technology's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$2.3 billion|
|Operating margin TTM||14.22%|
|Gross profit TTM||$1.7 billion|
|Return on assets TTM||6.01%|
|Return on equity TTM||80.12%|
|Market capitalisation||$41.6 billion|
TTM: trailing 12 months
There are currently 1.4 million Align Technology shares held short by investors – that's known as Align Technology's "short interest". This figure is 13.6% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Align Technology shares can be evaluated.
Align Technology's "short interest ratio" (SIR) is the quantity of Align Technology shares currently shorted divided by the average quantity of Align Technology shares traded daily (recently around 550456.48854962). Align Technology's SIR currently stands at 2.62. In other words for every 100,000 Align Technology shares traded daily on the market, roughly 2620 shares are currently held short.
To gain some more context, you can compare Align Technology's short interest ratio against those of similar companies.
However Align Technology's short interest can also be evaluated against the total number of Align Technology shares, or, against the total number of tradable Align Technology shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Align Technology's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Align Technology shares in existence, roughly 20 shares are currently held short) or 0.0206% of the tradable shares (for every 100,000 tradable Align Technology shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Align Technology.
Find out more about how you can short Align Technology stock.
We're not expecting Align Technology to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
You may also wish to consider:
Over the last 12 months, Align Technology's shares have ranged in value from as little as $127.88 up to $543.654. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Align Technology's is 1.6751. This would suggest that Align Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Align Technology's beta into context you can compare it against those of similar companies.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign Comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign Moderate, Lite and Express packages, and Invisalign Go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero Scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers; computer-aided design/computer-aided manufacturing services and ancillary products, such as disposable sleeves for the wand; and iTero applications and tools. The company sells its products in the United States, the Netherlands, China, and internationally. Align Technology, Inc. was founded in 1997 and is headquartered in San Jose, California.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.